<!DOCTYPE html>
<html lang="en">
<head>        <meta charset="utf-8">
        <meta name="viewport" content="width=device-width, initial-scale=1.0">    <link
        rel="stylesheet"
        href="https://maxcdn.bootstrapcdn.com/bootstrap/4.0.0/css/bootstrap.min.css"
        integrity="sha384-Gn5384xqQ1aoWXA+058RXPxPg6fy4IWvTNh0E263XmFcJlSAwiGgFAW/dAiS6JXm"
        crossorigin="anonymous"
    />
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/c3/0.6.12/c3.min.css"/>
    <style>
        h2 {
            margin-top: 35px;
        }

        html, body {
            height: 100%;
        }

        body {
            display: flex;
            flex-flow: column;
        }

        .footer {
            margin-top: auto;
            padding-top: 1em;
            background-color: #f5f5f5;
        }
    </style>    <title>BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP</title></head>

<body>
<nav class="navbar navbar-expand-lg navbar-light bg-light">
    <span class="navbar-brand">
        Molecular Signatures Database
    </span>
</nav>

<div class="container" style="margin-top: 50px; margin-bottom: 50px">
<div class="card">
        <div class="card-header">
            BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP
        </div>
        <div class="card-body">
                <p>Medulloblastoma (D-341 MED) and rhabdomyosarcoma (TE-671) cell lines, which are resistant to either 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) or the combination of BCNU and O6-benzylguanine (O6-BG), were generated by serial escalation of BCNU. The activities of O6-alkylguanine-DNA alkyltransferase (AGT), glutathione-S-transferase (GST), and total glutathione (GSH) of the parental, BCNU-resistant (BR), and BCNU + O6-BG-resistant (OBR) cells were measured. No significant differences in GST activity or total GSH were seen between the parental, BR, and OBR cells of both TE-671 and D-341 MED. The AGT activities of D-341 MED (BR) and TE-671 (BR) were twice those of D-341 MED and TE-671, respectively, confirming the importance of this enzyme for BCNU resistance. The D-341 MED (OBR) cells did not exhibit any AGT activity, suggesting that another mechanism must play a role in the drug resistance. Fewer DNA interstrand cross-links (ICLs) were observed in D-341 MED (OBR) than in D-341 MED after 8 h BCNU (100-400 microM) treatment. However, the amounts of DNA ICLs observed in D-341 MED and D-341 MED (OBR) were stable after 24 h. Microarray analysis showed the increased expressions of several metallothionein genes and down-regulation of several proapoptotic genes. The AGT activity of TE-671 (OBR) was 223 fmol/mg when the cells were grown in 10 microM O6-BG and decreased to about half this value when the O6-BG concentration was increased 60 microM. The AGT cDNA of TE-671 (OBR) cells was cloned and found to contain a G-to-T transversion at codon 156, resulting in conversion of glycine to cysteine (G156C). In vitro mutagenesis has shown that the G156C AGT mutant is resistant to inactivation by O6-BG. Thus, the selection of a mutant AGT with decreased sensitivity to O6-BG is a significant contributing factor to BCNU + O6-BG resistance.</p>
            <dl>
                <dt>Local Unique Identifier</dt>
                <dd><a href="https://bioregistry.io/msigdb:M15908">M15908</a>
                </dd>
                    <dt>
                        <span class="badge badge-primary">Relation</span>
                            in taxon (<code>RO:0002162</code>)
                    </dt>
                    <dt>
                        <ol>
                                <li><a href="https://bioregistry.io/NCBITaxon:9606">NCBITaxon:9606</a></li>
                        </ol>
                    </dt>
                    <dt>
                        <span class="badge badge-primary">Relation</span>
                            has part (<code>BFO:0000051</code>)
                    </dt>
                    <dt>
                        <ol>
                                <li><a href="https://bioregistry.io/ncbigene:3398">ncbigene:3398</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:4192">ncbigene:4192</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:6474">ncbigene:6474</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:8492">ncbigene:8492</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:26509">ncbigene:26509</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:4501">ncbigene:4501</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:3310">ncbigene:3310</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:3491">ncbigene:3491</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:23014">ncbigene:23014</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:6998">ncbigene:6998</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:4005">ncbigene:4005</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:2532">ncbigene:2532</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:4489">ncbigene:4489</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:1009">ncbigene:1009</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:5654">ncbigene:5654</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:8910">ncbigene:8910</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:8507">ncbigene:8507</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:416">ncbigene:416</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:5519">ncbigene:5519</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:10371">ncbigene:10371</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:760">ncbigene:760</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:4502">ncbigene:4502</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:9910">ncbigene:9910</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:4494">ncbigene:4494</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:3479">ncbigene:3479</a></li>
                        </ol>
                    </dt>
            </dl>
            <span class="badge badge-warning">Term generation via PyOBO is currently under construction</span>
            <blockquote>
                Term(reference=Reference(prefix=&#39;msigdb&#39;, identifier=&#39;M15908&#39;, name=&#39;BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP&#39;), definition=&#39;Medulloblastoma (D-341 MED) and rhabdomyosarcoma (TE-671) cell lines, which are resistant to either 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) or the combination of BCNU and O6-benzylguanine (O6-BG), were generated by serial escalation of BCNU. The activities of O6-alkylguanine-DNA alkyltransferase (AGT), glutathione-S-transferase (GST), and total glutathione (GSH) of the parental, BCNU-resistant (BR), and BCNU + O6-BG-resistant (OBR) cells were measured. No significant differences in GST activity or total GSH were seen between the parental, BR, and OBR cells of both TE-671 and D-341 MED. The AGT activities of D-341 MED (BR) and TE-671 (BR) were twice those of D-341 MED and TE-671, respectively, confirming the importance of this enzyme for BCNU resistance. The D-341 MED (OBR) cells did not exhibit any AGT activity, suggesting that another mechanism must play a role in the drug resistance. Fewer DNA interstrand cross-links (ICLs) were observed in D-341 MED (OBR) than in D-341 MED after 8 h BCNU (100-400 microM) treatment. However, the amounts of DNA ICLs observed in D-341 MED and D-341 MED (OBR) were stable after 24 h. Microarray analysis showed the increased expressions of several metallothionein genes and down-regulation of several proapoptotic genes. The AGT activity of TE-671 (OBR) was 223 fmol/mg when the cells were grown in 10 microM O6-BG and decreased to about half this value when the O6-BG concentration was increased 60 microM. The AGT cDNA of TE-671 (OBR) cells was cloned and found to contain a G-to-T transversion at codon 156, resulting in conversion of glycine to cysteine (G156C). In vitro mutagenesis has shown that the G156C AGT mutant is resistant to inactivation by O6-BG. Thus, the selection of a mutant AGT with decreased sensitivity to O6-BG is a significant contributing factor to BCNU + O6-BG resistance.&#39;, provenance=[Reference(prefix=&#39;pubmed&#39;, identifier=&#39;12479369&#39;, name=None)], relationships=defaultdict(&lt;class &#39;list&#39;&gt;, {TypeDef(reference=Reference(prefix=&#39;RO&#39;, identifier=&#39;0002162&#39;, name=&#39;in taxon&#39;), comment=None, namespace=None, definition=None, is_transitive=None, is_symmetric=None, domain=None, range=None, parents=[], xrefs=[], inverse=None, holds_over_chain=None): [Reference(prefix=&#39;NCBITaxon&#39;, identifier=&#39;9606&#39;, name=&#39;Homo sapiens&#39;)], TypeDef(reference=Reference(prefix=&#39;BFO&#39;, identifier=&#39;0000051&#39;, name=&#39;has part&#39;), comment=&#39;Inverse of part_of&#39;, namespace=None, definition=None, is_transitive=None, is_symmetric=None, domain=None, range=None, parents=[], xrefs=[], inverse=Reference(prefix=&#39;BFO&#39;, identifier=&#39;0000050&#39;, name=&#39;part of&#39;), holds_over_chain=None): [Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;3398&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;4192&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;6474&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;8492&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;26509&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;4501&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;3310&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;3491&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;23014&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;6998&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;4005&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;2532&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;4489&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;1009&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;5654&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;8910&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;8507&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;416&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;5519&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;10371&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;760&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;4502&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;9910&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;4494&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;3479&#39;, name=None)]}), properties=defaultdict(&lt;class &#39;list&#39;&gt;, {&#39;category_code&#39;: [&#39;C2&#39;], &#39;sub_category_code&#39;: [&#39;CGP&#39;], &#39;contributor&#39;: [&#39;John Newman&#39;], &#39;exact_source&#39;: [&#39;Table 1: signal ratio &gt; 3&#39;]}), parents=[], synonyms=[], xrefs=[], alt_ids=[], namespace=None, is_obsolete=False)
            </blockquote>
        </div>
    </div></div>

<footer class="footer">
    <p class="small text-center text-muted">
        Generated with PyOBO
    </p>
</footer>

<script src="https://code.jquery.com/jquery-3.2.1.slim.min.js"
        integrity="sha384-KJ3o2DKtIkvYIK3UENzmM7KCkRr/rE9/Qpg6aAZGJwFDMVNA/GpGFF93hXpG5KkN"
        crossorigin="anonymous"></script>
<script src="https://maxcdn.bootstrapcdn.com/bootstrap/4.0.0/js/bootstrap.min.js"
        integrity="sha384-JZR6Spejh4U02d8jOt6vLEHfe/JQGiRRSQQxSfFWpi1MquVdAyjUar5+76PVCmYl"
        crossorigin="anonymous"></script></body>
</html>